Migraine and sleep have a complex relationship, as inadequate sleep can trigger migraine attacks while adequate sleep plays a therapeutic role. Their pathophysiology is linked, as both involve the hypothalamus and common signaling molecules like serotonin and dopamine. Disorders like insomnia, obstructive sleep apnea, bruxism, and restless legs syndrome frequently coincide with migraine due to shared risk factors and pathophysiology. Maintaining adequate sleep is important for migraine management as it allows the brain's glymphatic system to remove waste and prevents trigger buildup.
Parasomnias in Neurological disoeders.pptxSwayang Panda
RBD is a REM sleep parasomnia characterized by loss of muscle atonia and dream enactment behaviors that can cause self or partner injury. It typically affects older males and is often preceded by neurodegenerative diseases like Parkinson's. Diagnosis involves abnormal motor behaviors and easy awakening during REM sleep. Treatment focuses on clonazepam to suppress REM sleep without dreams.
The document discusses migraine headaches, including:
- Migraines affect 15% of women and 6% of men and cause episodic throbbing headaches along with sensitivity to light, sound, and movement.
- Migraines can be divided into those with aura, preceded by neurological symptoms like visual disturbances, and those without aura.
- Familial hemiplegic migraine is a rare form of migraine with aura that runs in families and can include additional symptoms like weakness, fever, or seizures. It is caused by mutations in genes involved in ion transport in neurons.
The document provides an overview of sleep and sleep disorders presented by Dr. Kaushik Nandi. It discusses the neurobiology of sleep and wakefulness including the arousal spectrum and sleep/wake switch regulated by neurotransmitters and brain regions like the hypothalamus. The stages of sleep are described based on EEG patterns and physiological characteristics. Assessment methods and classifications of sleep disorders by the DSM-5 and ICSD-3 are outlined. Insomnia disorder and Narcolepsy are explained in more detail regarding their diagnostic criteria, epidemiology, etiology, pathophysiology and treatment approaches.
The document provides an overview of sleep disorders presented by Dr. Kaushik Nandi. It discusses the neurobiology of sleep and wakefulness, stages of sleep, assessment of sleep disorders, classification of sleep disorders, and management of common sleep disorders like insomnia, narcolepsy, hypersomnolence disorder, and breathing-related sleep disorders such as obstructive sleep apnea.
NREM sleep accounts for 75-80% of sleep time in adults and is divided into 3 stages - N1, N2, and N3. REM sleep makes up the remaining 20-25% and is characterized by low muscle tone and rapid eye movements. Common sleep disorders include insomnia, sleep apnea, restless leg syndrome, and narcolepsy. Obstructive sleep apnea is the most common sleep disorder and involves repetitive pauses in breathing during sleep due to upper airway collapse. Narcolepsy involves irresistible daytime sleep attacks and loss of muscle tone in response to emotions.
Sleep disorders affect around 32% of Canadians and there are over 100 identified types that can be grouped into problems falling/staying asleep, excessive daytime sleepiness, and irregular sleep schedules. Narcolepsy is characterized by excessive daytime sleepiness and cataplexy, where strong emotions trigger muscle weakness. It affects 1 in 2000 people and may be due to a lack of hypocretins that promote wakefulness. Current treatments include stimulants and modafinil, but research on orexin knockout mice and potential autoimmune factors continues to further understanding of this neurological sleep disorder.
Sleep is essential for health and cognitive function. It involves NREM and REM sleep stages measured using polysomnography. Common sleep disorders include insomnia, hypersomnolence, and narcolepsy. Insomnia is difficulty initiating or maintaining sleep and is treated with sleep hygiene, relaxation, and medication. Hypersomnolence involves excessive daytime sleepiness and is treated with stimulants. Narcolepsy involves REM sleep intrusion and is diagnosed by decreased REM latency on polysomnography.
Explores impact of disturbed sleep on symptom management in patients with concurrent serious illness and at the end of life. Presented during Hospice and Palliative Medicine Fellowship at the University of Kansas 2014
Parasomnias in Neurological disoeders.pptxSwayang Panda
RBD is a REM sleep parasomnia characterized by loss of muscle atonia and dream enactment behaviors that can cause self or partner injury. It typically affects older males and is often preceded by neurodegenerative diseases like Parkinson's. Diagnosis involves abnormal motor behaviors and easy awakening during REM sleep. Treatment focuses on clonazepam to suppress REM sleep without dreams.
The document discusses migraine headaches, including:
- Migraines affect 15% of women and 6% of men and cause episodic throbbing headaches along with sensitivity to light, sound, and movement.
- Migraines can be divided into those with aura, preceded by neurological symptoms like visual disturbances, and those without aura.
- Familial hemiplegic migraine is a rare form of migraine with aura that runs in families and can include additional symptoms like weakness, fever, or seizures. It is caused by mutations in genes involved in ion transport in neurons.
The document provides an overview of sleep and sleep disorders presented by Dr. Kaushik Nandi. It discusses the neurobiology of sleep and wakefulness including the arousal spectrum and sleep/wake switch regulated by neurotransmitters and brain regions like the hypothalamus. The stages of sleep are described based on EEG patterns and physiological characteristics. Assessment methods and classifications of sleep disorders by the DSM-5 and ICSD-3 are outlined. Insomnia disorder and Narcolepsy are explained in more detail regarding their diagnostic criteria, epidemiology, etiology, pathophysiology and treatment approaches.
The document provides an overview of sleep disorders presented by Dr. Kaushik Nandi. It discusses the neurobiology of sleep and wakefulness, stages of sleep, assessment of sleep disorders, classification of sleep disorders, and management of common sleep disorders like insomnia, narcolepsy, hypersomnolence disorder, and breathing-related sleep disorders such as obstructive sleep apnea.
NREM sleep accounts for 75-80% of sleep time in adults and is divided into 3 stages - N1, N2, and N3. REM sleep makes up the remaining 20-25% and is characterized by low muscle tone and rapid eye movements. Common sleep disorders include insomnia, sleep apnea, restless leg syndrome, and narcolepsy. Obstructive sleep apnea is the most common sleep disorder and involves repetitive pauses in breathing during sleep due to upper airway collapse. Narcolepsy involves irresistible daytime sleep attacks and loss of muscle tone in response to emotions.
Sleep disorders affect around 32% of Canadians and there are over 100 identified types that can be grouped into problems falling/staying asleep, excessive daytime sleepiness, and irregular sleep schedules. Narcolepsy is characterized by excessive daytime sleepiness and cataplexy, where strong emotions trigger muscle weakness. It affects 1 in 2000 people and may be due to a lack of hypocretins that promote wakefulness. Current treatments include stimulants and modafinil, but research on orexin knockout mice and potential autoimmune factors continues to further understanding of this neurological sleep disorder.
Sleep is essential for health and cognitive function. It involves NREM and REM sleep stages measured using polysomnography. Common sleep disorders include insomnia, hypersomnolence, and narcolepsy. Insomnia is difficulty initiating or maintaining sleep and is treated with sleep hygiene, relaxation, and medication. Hypersomnolence involves excessive daytime sleepiness and is treated with stimulants. Narcolepsy involves REM sleep intrusion and is diagnosed by decreased REM latency on polysomnography.
Explores impact of disturbed sleep on symptom management in patients with concurrent serious illness and at the end of life. Presented during Hospice and Palliative Medicine Fellowship at the University of Kansas 2014
We've all heard the term 'fat-burning', but how does it really happen in the body? Fat cells in the body release a hormone that signals to the brain that there is enough energy stored. This triggers your body to burn energy stored as fat
How is insomnia managed?
Cognitive behavioral therapy for insomnia (CBT-I) can help you control or eliminate negative thoughts and actions that keep you awake and is generally recommended as the first line of treatment for people with insomnia. Typically, CBT-I is equally or more effective than sleep medications.
MIGRAINE and it's treatment what is migraine, how much is it common and what ...imtiazali415911
Migraine is a common neurological condition affecting up to 30% of adults annually. It involves activation of the trigeminovascular system leading to neurogenic inflammation and sensitization. Migraines typically involve throbbing headache pain that may be preceded by aura and accompanied by nausea. Treatment involves both acute and preventative options. Acute treatments like NSAIDs and triptans aim to stop migraines early, while preventative medications are taken daily to reduce frequency.
This document discusses various sleep disorders and approaches to evaluating and treating patients with sleep problems. It covers topics like insomnia, obstructive sleep apnea, narcolepsy, restless leg syndrome, circadian rhythm disorders, and parasomnias. The key points are obtaining a thorough patient history, performing tests like polysomnography and multiple sleep latency tests to diagnose the underlying cause, and treating the specific disorder through lifestyle changes, medications, CPAP, or other therapies.
Title: Sleep Medicine: Unlocking the Secrets to a Restful Night's Sleep
Introduction:
Sleep is a fundamental aspect of human health and well-being, yet it remains a mysterious and often elusive phenomenon. The field of sleep medicine has emerged to shed light on the complex mechanisms of sleep, diagnose and treat sleep disorders, and ultimately improve the quality of life for millions of people worldwide. In this article, we delve into the fascinating realm of sleep medicine, exploring its importance, common sleep disorders, diagnostic techniques, treatment options, and the promising future of sleep research.
The Importance of Sleep:
Sleep plays a vital role in maintaining overall physical and mental health. It is during sleep that our bodies repair and rejuvenate, consolidating memories, regulating hormones, and supporting immune function. Insufficient or poor-quality sleep can have profound negative effects on our cognitive abilities, mood stability, cardiovascular health, and even our immune system. Understanding the importance of sleep highlights the critical role of sleep medicine in addressing sleep-related concerns.
Common Sleep Disorders:
Sleep medicine encompasses the diagnosis and treatment of various sleep disorders. Some of the most prevalent conditions include:
Insomnia: Characterized by difficulty falling asleep, staying asleep, or experiencing non-refreshing sleep, insomnia can lead to daytime fatigue, impaired concentration, and irritability.
Sleep Apnea: A condition where breathing is repeatedly interrupted during sleep, often due to the collapse of the airway. Sleep apnea can cause excessive daytime sleepiness, snoring, and an increased risk of cardiovascular problems.
Narcolepsy: A neurological disorder that affects the brain's ability to regulate sleep-wake cycles. People with narcolepsy experience excessive daytime sleepiness, sudden episodes of muscle weakness (cataplexy), and vivid hallucinations during sleep onset or upon awakening.
Restless Legs Syndrome (RLS): A neurological disorder characterized by an irresistible urge to move the legs, usually accompanied by uncomfortable sensations. RLS can disrupt sleep, leading to excessive daytime sleepiness and reduced quality of life.
Diagnostic Techniques:
Sleep medicine employs various diagnostic tools to identify and assess sleep disorders. Polysomnography (PSG) is a comprehensive sleep study that records brain waves, eye movements, heart rate, muscle activity, and oxygen levels during sleep. Multiple Sleep Latency Test (MSLT) evaluates daytime sleepiness by measuring the time it takes for an individual to fall asleep in a controlled environment. Additionally, actigraphy and questionnaires help gather data on sleep patterns and subjective experiences.
Treatment Options:
Treatment for sleep disorders depends on the specific diagnosis and severity of symptoms. Some common treatment modalities in sleep medicine include:
Lifestyle Modifications: Adopting healthy sleep h
Migraine is a common neurological disorder characterized by recurrent headaches. It has strong genetic components and is believed to involve a hyperexcitable brain and trigeminovascular system. The pathophysiology involves cortical spreading depression, activation of the trigeminal nerve, and neurovascular inflammation. Treatment involves identifying and avoiding triggers, acute medications like triptans, and preventive strategies. Management requires patient education and a collaborative approach.
Metabolic and Endocrine Consequences of Abnormal Human Sleep.pdfAhmed Elshebiny
The document discusses the metabolic and endocrine consequences of abnormal human sleep. It notes that sleep and hormones are interrelated, with short sleep durations being associated with conditions like obesity, diabetes, hypertension, and cardiovascular disease. Certain hormones like growth hormone, prolactin, and melatonin promote sleep, while cortisol and androgen increase awareness and reduce sleep. The document recommends screening patients for sleep disorders, insufficient sleep, or obstructive sleep apnea, as fatigue may result from endocrine or sleep issues.
The document discusses sleep, insomnia, and their treatment. It defines insomnia as difficulty initiating or maintaining sleep. Insomnia can be transient, acute, or chronic. Common causes include medical, psychiatric, substance-related, and circadian issues. Treatment involves addressing underlying causes, improving sleep hygiene, cognitive-behavioral therapy including stimulus control and sleep restriction, and may include pharmacotherapy with hypnotics as a short-term option. Multicomponent cognitive behavioral therapy is most effective for insomnia.
This document discusses NREM sleep arousal disorders. It begins with an overview and introduction to sleep organization and characteristics of NREM and REM sleep. It then discusses several specific NREM sleep disorders - sleepwalking, sleep terrors, and confusional arousals. Tools for sleep monitoring like polysomnography and the multiple sleep latency test are also summarized. Sleep-related eating disorder is defined. Throughout, the stages of NREM sleep are contrasted with REM sleep and the clinical features of specific disorders are outlined.
The document discusses sleep disorders and the measurement and stages of sleep. It provides details on:
1) How sleep is measured using EEG, EOG, and EMG electrodes to record brain waves, eye movements, and muscle activity.
2) The stages of sleep including NREM stages 1-4 and REM sleep, characterized by different brain wave patterns.
3) Common sleep disorders like insomnia, hypersomnia, sleep apnea, circadian rhythm disorders and parasomnias. Treatment options are also outlined.
The document discusses sleep disorders and how sleep is measured. It describes the stages of sleep including non-rapid eye movement sleep (NREM) and rapid eye movement sleep (REM). NREM sleep is divided into 4 stages characterized by different brain wave patterns. The cycles between NREM and REM sleep are important for rest. Common sleep disorders include primary insomnia, hypersomnia, narcolepsy, and sleep apnea. Insomnia involves difficulty initiating or maintaining sleep while hypersomnia involves excessive daytime sleepiness. Breathing-related disorders disrupt sleep through interrupted breathing.
Headache and epilepsy are commonly comorbid conditions that share underlying pathophysiological mechanisms. About 5-10% of those with migraine have epilepsy, and 8-15% of those with epilepsy experience migraine. Both involve neuronal hyperexcitability that can trigger cortical spreading depression or seizures. Genetic channelopathies like FHM types 1-3 alter neuronal calcium and sodium channel function, lowering seizure and migraine thresholds. Antiepileptic drugs like levetiracetam and zonisamide can treat both conditions. Careful history is needed to identify pre-ictal headaches in those with epilepsy and evaluate for epilepsy in migraine patients due to medication interactions.
This document discusses sleep physiology and sleep disorders. It begins by defining sleep and outlining the three basic physiological processes of wakefulness, non-rapid eye movement (NREM) sleep, and rapid eye movement (REM) sleep. It then describes sleep architecture and the stages of NREM and REM sleep in detail. Key aspects of sleep such as circadian rhythms, sleep requirements, neurobiology, and disorders like insomnia are also summarized. The document provides an overview of normal sleep patterns and processes as well as common sleep disorders.
This document provides an overview of the assessment and management of insomnia. It discusses evaluating insomnia through sleep history, sleep diaries, polysomnography and assessing daytime sleepiness. It covers differentiating insomnia from other sleep disorders and identifying predisposing, precipitating and perpetuating factors. Management techniques discussed include sleep hygiene, relaxation therapy, sleep scheduling, cognitive therapy and sleep medications. Specific instructions are provided for implementing relaxation exercises, sleep scheduling and cognitive approaches like challenging dysfunctional beliefs. The risks and benefits of different medication classes are also summarized.
This document summarizes diagnosis and management of trigeminal neuralgia. It describes the anatomy of the trigeminal nerve and its three divisions. Trigeminal neuralgia is characterized by sudden, severe facial pain that occurs in short bursts and is triggered by light touch. The underlying cause is typically vascular compression of the trigeminal nerve root. Diagnosis is based on clinical history and MRI to rule out other causes. Treatment involves carbamazepine medication or microvascular decompression surgery to address the underlying compression.
Migraine is a common type of primary headache characterized by recurrent attacks of moderate to severe pulsating headache accompanied by nausea, vomiting, and sensitivity to light and sound. It is classified into migraine with aura and migraine without aura, and treatment involves both acute abortive medications as well as preventive medications and lifestyle modifications to reduce triggers and attack frequency. Diagnosis is based on clinical history and examination along with diagnostic criteria, while management involves a multifaceted approach including both pharmacological and non-pharmacological options.
Migraine aura is a neurological symptom that occurs prior to headache in migraine attacks. It is characterized by visual, sensory or other neurological symptoms that develop gradually over time. Common visual aura symptoms include flashing lights or vision distortions. Migraine aura is thought to involve cortical spreading depression, a wave of neuronal and glial cell excitation that spreads across the brain. While migraine aura is a risk factor for stroke, there is no strong evidence linking it to patent foramen ovale. Treatment of migraine attacks involving aura is generally the same as for attacks without aura, with the exception that transcranial magnetic stimulation is specifically approved for acute treatment of aura.
Multiple Sclerosis and Sleep - A Different PerspectiveMS Trust
Neil Stanley is an independent sleep expert with over 37 years of experience in sleep research. He has worked at several research institutions and hospitals and is a member of several sleep societies. Sleep disorders in people with conditions like multiple sclerosis often remain underreported, underdiagnosed, and undertreated. A recent study found that 74% of MS patients studied had sleep disorders. Sleep plays an important role in the immune system, endocrine system, and brain function. Multiple sclerosis can cause or exacerbate existing sleep problems like insomnia, sleep apnea, and restless legs syndrome. Effective treatment of sleep disorders and underlying MS symptoms is important for managing pain, fatigue, mood, and daytime sleepiness in patients.
We've all heard the term 'fat-burning', but how does it really happen in the body? Fat cells in the body release a hormone that signals to the brain that there is enough energy stored. This triggers your body to burn energy stored as fat
How is insomnia managed?
Cognitive behavioral therapy for insomnia (CBT-I) can help you control or eliminate negative thoughts and actions that keep you awake and is generally recommended as the first line of treatment for people with insomnia. Typically, CBT-I is equally or more effective than sleep medications.
MIGRAINE and it's treatment what is migraine, how much is it common and what ...imtiazali415911
Migraine is a common neurological condition affecting up to 30% of adults annually. It involves activation of the trigeminovascular system leading to neurogenic inflammation and sensitization. Migraines typically involve throbbing headache pain that may be preceded by aura and accompanied by nausea. Treatment involves both acute and preventative options. Acute treatments like NSAIDs and triptans aim to stop migraines early, while preventative medications are taken daily to reduce frequency.
This document discusses various sleep disorders and approaches to evaluating and treating patients with sleep problems. It covers topics like insomnia, obstructive sleep apnea, narcolepsy, restless leg syndrome, circadian rhythm disorders, and parasomnias. The key points are obtaining a thorough patient history, performing tests like polysomnography and multiple sleep latency tests to diagnose the underlying cause, and treating the specific disorder through lifestyle changes, medications, CPAP, or other therapies.
Title: Sleep Medicine: Unlocking the Secrets to a Restful Night's Sleep
Introduction:
Sleep is a fundamental aspect of human health and well-being, yet it remains a mysterious and often elusive phenomenon. The field of sleep medicine has emerged to shed light on the complex mechanisms of sleep, diagnose and treat sleep disorders, and ultimately improve the quality of life for millions of people worldwide. In this article, we delve into the fascinating realm of sleep medicine, exploring its importance, common sleep disorders, diagnostic techniques, treatment options, and the promising future of sleep research.
The Importance of Sleep:
Sleep plays a vital role in maintaining overall physical and mental health. It is during sleep that our bodies repair and rejuvenate, consolidating memories, regulating hormones, and supporting immune function. Insufficient or poor-quality sleep can have profound negative effects on our cognitive abilities, mood stability, cardiovascular health, and even our immune system. Understanding the importance of sleep highlights the critical role of sleep medicine in addressing sleep-related concerns.
Common Sleep Disorders:
Sleep medicine encompasses the diagnosis and treatment of various sleep disorders. Some of the most prevalent conditions include:
Insomnia: Characterized by difficulty falling asleep, staying asleep, or experiencing non-refreshing sleep, insomnia can lead to daytime fatigue, impaired concentration, and irritability.
Sleep Apnea: A condition where breathing is repeatedly interrupted during sleep, often due to the collapse of the airway. Sleep apnea can cause excessive daytime sleepiness, snoring, and an increased risk of cardiovascular problems.
Narcolepsy: A neurological disorder that affects the brain's ability to regulate sleep-wake cycles. People with narcolepsy experience excessive daytime sleepiness, sudden episodes of muscle weakness (cataplexy), and vivid hallucinations during sleep onset or upon awakening.
Restless Legs Syndrome (RLS): A neurological disorder characterized by an irresistible urge to move the legs, usually accompanied by uncomfortable sensations. RLS can disrupt sleep, leading to excessive daytime sleepiness and reduced quality of life.
Diagnostic Techniques:
Sleep medicine employs various diagnostic tools to identify and assess sleep disorders. Polysomnography (PSG) is a comprehensive sleep study that records brain waves, eye movements, heart rate, muscle activity, and oxygen levels during sleep. Multiple Sleep Latency Test (MSLT) evaluates daytime sleepiness by measuring the time it takes for an individual to fall asleep in a controlled environment. Additionally, actigraphy and questionnaires help gather data on sleep patterns and subjective experiences.
Treatment Options:
Treatment for sleep disorders depends on the specific diagnosis and severity of symptoms. Some common treatment modalities in sleep medicine include:
Lifestyle Modifications: Adopting healthy sleep h
Migraine is a common neurological disorder characterized by recurrent headaches. It has strong genetic components and is believed to involve a hyperexcitable brain and trigeminovascular system. The pathophysiology involves cortical spreading depression, activation of the trigeminal nerve, and neurovascular inflammation. Treatment involves identifying and avoiding triggers, acute medications like triptans, and preventive strategies. Management requires patient education and a collaborative approach.
Metabolic and Endocrine Consequences of Abnormal Human Sleep.pdfAhmed Elshebiny
The document discusses the metabolic and endocrine consequences of abnormal human sleep. It notes that sleep and hormones are interrelated, with short sleep durations being associated with conditions like obesity, diabetes, hypertension, and cardiovascular disease. Certain hormones like growth hormone, prolactin, and melatonin promote sleep, while cortisol and androgen increase awareness and reduce sleep. The document recommends screening patients for sleep disorders, insufficient sleep, or obstructive sleep apnea, as fatigue may result from endocrine or sleep issues.
The document discusses sleep, insomnia, and their treatment. It defines insomnia as difficulty initiating or maintaining sleep. Insomnia can be transient, acute, or chronic. Common causes include medical, psychiatric, substance-related, and circadian issues. Treatment involves addressing underlying causes, improving sleep hygiene, cognitive-behavioral therapy including stimulus control and sleep restriction, and may include pharmacotherapy with hypnotics as a short-term option. Multicomponent cognitive behavioral therapy is most effective for insomnia.
This document discusses NREM sleep arousal disorders. It begins with an overview and introduction to sleep organization and characteristics of NREM and REM sleep. It then discusses several specific NREM sleep disorders - sleepwalking, sleep terrors, and confusional arousals. Tools for sleep monitoring like polysomnography and the multiple sleep latency test are also summarized. Sleep-related eating disorder is defined. Throughout, the stages of NREM sleep are contrasted with REM sleep and the clinical features of specific disorders are outlined.
The document discusses sleep disorders and the measurement and stages of sleep. It provides details on:
1) How sleep is measured using EEG, EOG, and EMG electrodes to record brain waves, eye movements, and muscle activity.
2) The stages of sleep including NREM stages 1-4 and REM sleep, characterized by different brain wave patterns.
3) Common sleep disorders like insomnia, hypersomnia, sleep apnea, circadian rhythm disorders and parasomnias. Treatment options are also outlined.
The document discusses sleep disorders and how sleep is measured. It describes the stages of sleep including non-rapid eye movement sleep (NREM) and rapid eye movement sleep (REM). NREM sleep is divided into 4 stages characterized by different brain wave patterns. The cycles between NREM and REM sleep are important for rest. Common sleep disorders include primary insomnia, hypersomnia, narcolepsy, and sleep apnea. Insomnia involves difficulty initiating or maintaining sleep while hypersomnia involves excessive daytime sleepiness. Breathing-related disorders disrupt sleep through interrupted breathing.
Headache and epilepsy are commonly comorbid conditions that share underlying pathophysiological mechanisms. About 5-10% of those with migraine have epilepsy, and 8-15% of those with epilepsy experience migraine. Both involve neuronal hyperexcitability that can trigger cortical spreading depression or seizures. Genetic channelopathies like FHM types 1-3 alter neuronal calcium and sodium channel function, lowering seizure and migraine thresholds. Antiepileptic drugs like levetiracetam and zonisamide can treat both conditions. Careful history is needed to identify pre-ictal headaches in those with epilepsy and evaluate for epilepsy in migraine patients due to medication interactions.
This document discusses sleep physiology and sleep disorders. It begins by defining sleep and outlining the three basic physiological processes of wakefulness, non-rapid eye movement (NREM) sleep, and rapid eye movement (REM) sleep. It then describes sleep architecture and the stages of NREM and REM sleep in detail. Key aspects of sleep such as circadian rhythms, sleep requirements, neurobiology, and disorders like insomnia are also summarized. The document provides an overview of normal sleep patterns and processes as well as common sleep disorders.
This document provides an overview of the assessment and management of insomnia. It discusses evaluating insomnia through sleep history, sleep diaries, polysomnography and assessing daytime sleepiness. It covers differentiating insomnia from other sleep disorders and identifying predisposing, precipitating and perpetuating factors. Management techniques discussed include sleep hygiene, relaxation therapy, sleep scheduling, cognitive therapy and sleep medications. Specific instructions are provided for implementing relaxation exercises, sleep scheduling and cognitive approaches like challenging dysfunctional beliefs. The risks and benefits of different medication classes are also summarized.
This document summarizes diagnosis and management of trigeminal neuralgia. It describes the anatomy of the trigeminal nerve and its three divisions. Trigeminal neuralgia is characterized by sudden, severe facial pain that occurs in short bursts and is triggered by light touch. The underlying cause is typically vascular compression of the trigeminal nerve root. Diagnosis is based on clinical history and MRI to rule out other causes. Treatment involves carbamazepine medication or microvascular decompression surgery to address the underlying compression.
Migraine is a common type of primary headache characterized by recurrent attacks of moderate to severe pulsating headache accompanied by nausea, vomiting, and sensitivity to light and sound. It is classified into migraine with aura and migraine without aura, and treatment involves both acute abortive medications as well as preventive medications and lifestyle modifications to reduce triggers and attack frequency. Diagnosis is based on clinical history and examination along with diagnostic criteria, while management involves a multifaceted approach including both pharmacological and non-pharmacological options.
Migraine aura is a neurological symptom that occurs prior to headache in migraine attacks. It is characterized by visual, sensory or other neurological symptoms that develop gradually over time. Common visual aura symptoms include flashing lights or vision distortions. Migraine aura is thought to involve cortical spreading depression, a wave of neuronal and glial cell excitation that spreads across the brain. While migraine aura is a risk factor for stroke, there is no strong evidence linking it to patent foramen ovale. Treatment of migraine attacks involving aura is generally the same as for attacks without aura, with the exception that transcranial magnetic stimulation is specifically approved for acute treatment of aura.
Multiple Sclerosis and Sleep - A Different PerspectiveMS Trust
Neil Stanley is an independent sleep expert with over 37 years of experience in sleep research. He has worked at several research institutions and hospitals and is a member of several sleep societies. Sleep disorders in people with conditions like multiple sclerosis often remain underreported, underdiagnosed, and undertreated. A recent study found that 74% of MS patients studied had sleep disorders. Sleep plays an important role in the immune system, endocrine system, and brain function. Multiple sclerosis can cause or exacerbate existing sleep problems like insomnia, sleep apnea, and restless legs syndrome. Effective treatment of sleep disorders and underlying MS symptoms is important for managing pain, fatigue, mood, and daytime sleepiness in patients.
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
2. INTRODUCTION
Migraine and sleep - a complex relationship
Inadequate sleep – trigger for migraine attack
Adequate sleep – can have a therapeutic role in migraine
Common pathophysiology is suggested by
Anatomic localization (hypothalamus)
Common mediating signaling molecules (serotonin and dopamine)
CNS waste removal (glymphatic system)
Treatment with medication having sedative effect – may be necessary
Neurology 2016;87:309–313.
Headache. 2018 July ; 58(7): 1030–1039
3. WHY WE SLEEP? - SLEEP MECHANISM
Sleep performs restorative role
Helps in eliminating brain waste build up during day course
Hypothalamus - the key player
Sleep induction: Hypothalamus abruptly shut off the augmentation of
wakefulness pathways and simultaneously turn on sleep promoting pathways
by sending inhibitory output to arousal pathways
Chest 2015;147:1179–1192.
Nature 2005;437:1257–1263
4. PHYSIOLOGICAL CHANGES DURING SLEEP
Cortical activity : Slow downs (over seconds to 1 minute) to NREM sleep
pattern
Wave Progression: Slower reaching to Delta Wave (Lasting for 40 min to 1
hour) : initiation of restorative activity
Abruption into REM sleep: Attributes both hypothalamic flip flop switch as
well as mesopontine tegmentum.
Loss of muscle tone: REM (Dream/Nightmares)
Age factor : Decrease in restorative sleep and increase in night time arousals
due to age progression
Sleep 1995;18:880–889
Semin Respir Crit Care Med 2010;31:618–633
J Sleep Res 1992;1:122–124
5. PATHOPHYSIOLOGY & MECHANISMS
Bidirectional interactions - relationship between Sleep and Migraine.
Nocturnal migraine
may disrupt sleep
decreases sleep frequency
Common underlying pathophysiology
Increased neuroscientific evidence
new discoveries on anatomic localization
roles of common mediating signaling molecules
discovery of a new CNS waste removal system
Neurology 2016;87:309–313.
Headache. 2018 July ; 58(7): 1030–
1039
6. MIGRAINE & SLEEP DISORDER : INSOMNIA
Insomnia: Difficulty with sleep initiation or maintenance with daytime
consequences despite adequate opportunity
Most prevalent sleep complaint : contributing 1/3rd population with symptoms
while 6% general population with chronic insomnia.
Symptoms coincide with migraine:
- Increased heart rate - Difficulty initiating sleep
- Increased cortisol levels - Inadequate sleep
- High frequency activity - lack of refreshment after sleep
Am J Psychiatry 1979;136:1257–1262.
Sleep Med Rev 2002;6:97–111.
Headache 2005;45:904–910
Sleep Med 2003;4:385–391
J Headache Pain 2010;11:197–206.
Ann Indian Acad Neurol 2008;11:164–169
7. MIGRAINE & SLEEP DISORDER : INSOMNIA
Frequent complaints of insomnia with migraine led to the possibilities of sleep
triggers in migraine endophenotype
Sleep latency : Shown decrease in the sleep quality, efficiency and amount of
slow wave in the patient with migraine
REM sleep and headache disorder : Lower arousal index during REM sleep and
lower cyclic alternating pattern at baseline is seen in the patient with migraine
Sleep Breath 2016;20:263–269
Pediatr Neurol 2008;39:6–11
J Headache Pain 2013;14:68.
Cephalalgia 2003;23:150–154
8. MIGRAINE & SLEEP DISORDER : INSOMNIA
2/3rd of patients with migraine - occasional headaches disturbing sleep
cycle
Insomnia during early morning migraine attacks
Early morning migraine attacks increases with the age factor:
16% patients twenties
58% patients >60 years old.
Insomnia if untreated in migraine – may affect quality of life
CBT treatment
Improvement in insomnia
reduces headache in migraine
Headache 2007;47:1184–1188
Acta Neurol Belg 2012;112:183–187
9. MIGRAINE & SLEEP DISORDER: OBSTRUCTIVE SLEEP
APNEA
OSA - Related to the symptoms of sleep apnoea
Pattern of Symptoms varies like
-> Associated with Sleep Apnoea:
Sleepiness, Fatigue, Insomnia, Snoring, Subjective nocturnal and respiratory
disturbance.
-> Associated medical or psychiatric disorder includes:
Hypertension, Coronary artery disease, Atrial fibrillation, CHF, Stroke,
diabetes, Cognitive dysfunction, or mood disorder
Absence of associated symptoms or disorders: ≥15 obstructive respiratory
events per hour satisfies the criteria
Chest 2014;146:1387–1394
10. MIGRAINE & SLEEP DISORDER: OBSTRUCTIVE SLEEP
APNEA
Migraine attacks in the morning – Associated with breathing difficulties
snoring and sleep apnoea
Polysomnographic studies
patients with migraine have similar sleep apnea as the general
population.
Shared risk factor for Migraine: Daily headaches, breathing difficulties,
snoring and obesity
Arch Intern Med 1999;159:1765–1768
Dent Clin North Am 2001;45:685–700.
Sleep and migraine: An actigraphic study. Cephalalgia 2004;24:134–139.
Pain 1993;53:65–72
11. MIGRAINE & SLEEP DISORDER: OBSTRUCTIVE SLEEP
APNOEA
Low threshold for hypoxemia inducing headaches of OSA - can occur in the
patient with migraine
Both migraine and OSA are commonly encountered
The underdiagnosed OSA in migraine – may lead to future vascular events
Clinical evaluation of migraine - should also include OSA screening
Headache 2008;48:16–25.
12. MIGRAINE & SLEEP DISORDER:
PARASOMNIAS & SLEEP-RELATED MOVEMENT
Dopamine – an important neurotransmitter in migraine pathophysiology
Dopaminergic dysfunction implicates parasomnias and sleep-related movement disorders in
several neurologic diseases
Dopamine dysfunction may trigger migraine prodrome
Common disorders in migraine
Non-REM parasomnia
Bruxism
Restless legs syndrome
Cephalalgia 2007;27:1308–1314.
13. MIGRAINE & SLEEP DISORDER: SOMNAMBULISM
Studies of both children and adult with migraine
Higher rate of childhood Somnambulism
predominate in the patient of migraine with aura
Increased Somnambulism in children – may be seen in migraine or tension type headache
Symptoms like Motion sickness, recurrent limb pain, recurrent abdominal pain, sleep talking,
and bruxism - prevalent in children with migraine
Adult migraine patient
May have childhood somnambulism (33%)
relationship even persists when they are controlled for depression, daytime sleepiness and
insomnia
Cephalalgia 1997;17:492–498
Neurology 2005;65:1334–1335
Pediatr Neurol 2010;43:420–424
14. MIGRAINE & SLEEP DISORDER: BRUXISM
Bruxism with temporomandibular joint dysfunction (TMD)
highly prevalent with the migraine patient
Bruxism
trigger migraine attack in association with TMD
increased peripheral activities of trigeminal nerve
Same central etiologies proposes sleep bruxism-migraine association
sleep microarousals
sleep transitions
Clin J Pain 2017;33:835–843.
Clin Pediatr (Phila) 2015;54:469–478
J Orofac Pain 2013;27:14–20.
15. MIGRAINE & SLEEP DISORDER: RESTLESS LEGS
SYNDROME
RLS and migraine: decrease in sleep efficiency or difficulty initiating sleep
Dopamine plays important role
Dopamine dysfunction leads to RLS - decreased A11 neuron from Hypothalamus to the
spinal cord
Migraine
higher frequency of dream-enacting behavior (DEB)
worse headache-related disability
increased frequency of nightmares
Cephalalgia 2014;34:777–794
Eur J Neurol 2014;21:1205–1210
Mov Disord 2007;22:1451–1456
Cephalalgia 2007;27:1308–1314.
16. MIGRAINE & SLEEP DISORDER: NARCOLEPSY
Increased level of tension type of headache and migraine in the patient with
Narcolepsy.
Clinical statistics reports :
-> 23.5% increased rate of migraine
-> 41.2% with primary hypersomnia
Further research is ongoing to evaluate the clinical relationship between Narcolepsy
and migraine
Cephalalgia 2003;23:786– 789.
Cephalalgia 2003;23:14–19
17. MIGRAINE & SLEEP DISORDER: NARCOLEPSY IN CHILDREN
13 incident cases with narcolepsy – children – 0-17 yrs
Patients with Migraine
a greater risk of developing narcolepsy than patients without migraine
adjusted hazard ratio = 5.30, 95% CI: 1.61, 17.4; p = 0.006
Persisted after controlling for potential confounders - baseline
comorbidities and concurrent medication uptake, migraine subtypes.
PLoS One. 2017; 12(12): e0189231.
Migraine is an independent risk factor for narcolepsy development in children.
18. SLEEP FACTOR: MIGRAINE INFLUENCER
Insomnia - part of the migraine prodrome or incites the migraine attack
Frequent nighttime awakenings - sleep-related migraine attacks
Serotonin (5-HT) vital role - regulates sleep, mood (depression and anxiety), appetite, sexual function,
and pain
Serotonin: responsible for wakefulness and inhibit REM sleep
In migraine
Low serotonin state interictally
Increased 5HT movement from intracellular store early migraine attack
Sleep 2007;30:494–505
Cephalalgia 2006;26:1225–1233
J Neurol 2007;254:789–796
19. SLEEP FACTOR: MIGRAINE INFLUENCER
How serotonin levels - participate in the trigeminovascular nociceptive
pathway is unclear
The transition from NREM to REM sleep is based on dorsal raphe nucleus
cessation of serotonin neuron firing is vital in initiating REM
Decreased in the REM cycle in case of migraine possibly due to dysfunction of
serotonin.
Sleep Breath 2016;20:263–26
Headache 2006;46:34–39
Am J Physiol 1997;273:R451–455
20. SLEEP FACTOR: MIGRAINE INFLUENCER
Hypothalamus: Targeted as a central & early player in migraine pathophysiology
PET imaging
alteration in the hypothalamus activity and coupling of spinal trigeminal nuclei
with in 24 hours of pain onset
Hypothalamus: Implicated in migraine by producing gonadotropin-releasing
hormone.
With serotonin, Dopamine also plays important role in monitoring pre phase of
migraine.
Dopamine modulating neuronal firing: suggested by Symptoms like
yawning, drowsiness, mood changes, irritability, and hyperactivity
Nature 2005;437:1257–1263
Ann N Y Acad Sci 2008;1129:275–
286.
Neurol Sci 2008;29(Suppl 1):S166–
21. ADEQUATE SLEEP: AS MIGRAINE THERAPEUTIC
Sleep disruption
↓
Disturbances in glymphatic flow
↓
Accumulation of waste products
↓
Trigger migraine
J Neurosci 2017;37:2904–2915
22. ADEQUATE SLEEP: AS MIGRAINE THERAPEUTIC
Chronic sleep disruption
↓
Accumulation of more toxic substances
(e.g. beta-amyloid and metalloproteinases)
↓
Chronic Migraine
23. ADEQUATE SLEEP: AS MIGRAINE THERAPEUTIC
Sleep can often terminate a migraine attack
Restorative impact of sleep helps in tackling migraine attack - may not be effective in
chronic migraine
Sleep - facilitates and restores brains day time activity.
Glymphatic System is active during sleep
Removes the interstitial waste via perivascular space created by astrocytic end feet
Restorative role of glymphatic system has shown the possible mechanism in the
migraine management
Science 2013;342:373–377.
24. CONCLUSION
Sleep and migraine relationship - common pathophysiology.
Received more attention in the last 2 decades
Clinical approach should be to view the cause of migraine pathophysiology linked to sleep
problems
Further research to drive possible migraine management mechanism
Treatment of sleep problems in patients with migraine will also help in reducing headache
days and disability.